Dionysios V. Chartoumpekis

Author

Also Known As

D. Chartoumpekis, D.V. Chartoumpekis, Dionysios Chartoumpekis, Dionysios V Chartoumpekis, Dionysios V. Chartoumpekis, Dionysios V. Chartoumpekis, Dionysius V Chartoumpekis

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

University of Patras University of Pittsburgh University of Lausanne National and Kapodistrian University of Athens Tohoku University

About

Dionysios V. Chartoumpekis is an author at University of Patras specializing in medicine, oxidative stress, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	995
2	Health Sciences	8	8	569
3	Cell Biology	5	5	250
4	Allergy	3	3	95
5	Biochemistry	2	2	173

Dionysios V. Chartoumpekis

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Brown Adipose Tissue Responds to Cold and Adrenergic Stimulation by Induction of FGF21 Dionysios V. Chartoumpekis, Ioannis Habeos, Panos G. Ziros, Molecular Medicine	2011	243
Differential Expression of MicroRNAs in Adipose Tissue after Long-Term High-Fat Diet-Induced Obesity in Mice Dionysios V. Chartoumpekis, Apostolos Zaravinos, Panos G. Ziros, PLoS ONE PathologyObesity PreventionObesityMetabolic SyndromeInflammation	2012	242
Nrf2 Represses FGF21 During Long-Term High-Fat Diet–Induced Obesity in Mice Dionysios V. Chartoumpekis, Panos G. Ziros, Agathoklis Psyrogiannis, Diabetes	2011	180
Notch-Nrf2 Axis: Regulation of <i>Nrf2</i> Gene Expression and Cytoprotection by Notch Signaling Nobunao Wakabayashi, John Skoko, Dionysios V. Chartoumpekis, Molecular and Cellular Biology Notch-nrf2 AxisCholangiopathiesOxidative StressTranscriptional RegulationSignaling Pathway	2013	127
Keap1/Nrf2 pathway activation leads to a repressed hepatic gluconeogenic and lipogenic program in mice on a high-fat diet Stephen L. Slocum, John Skoko, Nobunao Wakabayashi, Archives of Biochemistry and Biophysics ObesityMetabolic SyndromeHealth SciencesBiochemistryLiver Physiology	2015	101
Withaferin A induces Nrf2-dependent protection against liver injury: Role of Keap1-independent mechanisms Dushani L. Palliyaguru, Dionysios V. Chartoumpekis, Nobunao Wakabayashi, Free Radical Biology and Medicine ImmunologyCell DeathOxidative StressInflammationHepatotoxicity	2016	93
Simvastatin activates Keap1/Nrf2 signaling in rat liver Ioannis Habeos, Panos G. Ziros, Dionysios V. Chartoumpekis, Journal of Molecular Medicine InflammationSignal TransductionMedicineLiver PhysiologyPhysiology	2008	75
Simvastatin lowers reactive oxygen species level by Nrf2 activation via PI3K/Akt pathway Dionysios V. Chartoumpekis, Panos G. Ziros, Agathoklis Psyrogiannis, Biochemical and Biophysical Research Communications InflammationReductive StressBiochemistryAtherosclerosisMedicine	2010	72
Genetic or pharmacologic Nrf2 activation increases proteinuria in chronic kidney disease in mice Brittney M. Rush, Corry D. Bondi, Sean D. Stocker, Kidney International GlomerulonephritisUrologyRenal DiseaseRenal FunctionMedicine	2020	59
Nrf2 deletion from adipocytes, but not hepatocytes, potentiates systemic metabolic dysfunction after long-term high-fat diet-induced obesity in mice Dionysios V. Chartoumpekis, Dushani L. Palliyaguru, Nobunao Wakabayashi, American Journal of Physiology-Endocrinology and Metabolism Metabolic DisorderImmunologyFatty Liver DiseaseGlucose ToleranceTargeted Deletion	2018	53

Page 1